Exendin-4-mediated cell proliferation in beta-cells: focusing on the transcription factors

Similar documents
Defects in glucose utilization & GLP-1

NIH Public Access Author Manuscript Diabetologia. Author manuscript; available in PMC 2014 February 01.

Identification of GLP1R agonists using a novel high throughput screening assay Wan Namkung, Ph.D.

Megan Lawless. Journal Club. January 20 th, 2011

GPR120 *** * * Liver BAT iwat ewat mwat Ileum Colon. UCP1 mrna ***

Scope. History. History. Incretins. Incretin-based Therapy and DPP-4 Inhibitors

Chief of Endocrinology East Orange General Hospital

Div. of Endocrinology and Metabolism Konyang University, School of Medicine. Byung-Joon Kim M.D., Ph.D.

/05/$15.00/0 Molecular Endocrinology 19(5): Copyright 2005 by The Endocrine Society doi: /me

ENERGY FROM INGESTED NUTREINTS MAY BE USED IMMEDIATELY OR STORED

Gut hormones KHATTAB

Type 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM

22 Emerging Therapies for

EAT TO LIVE: THE ROLE OF THE PANCREAS. Felicia V. Nowak, M.D., Ph.D. Ohio University COM 22 January, 2008

Principles of Genetics and Molecular Biology

Intracellular signalling cascades associated with TRP channels

Practical Strategies for the Clinical Use of Incretin Mimetics CME/CE. CME/CE Released: 09/15/2009; Valid for credit through 09/15/2010

/06/$15.00/0 Molecular Endocrinology 20(9): Copyright 2006 by The Endocrine Society doi: /me

Discussion & Conclusion

Result of screening and surveillance colonoscopy in young Korean adults < 50 years

GLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION.

Figure legends Supplemental Fig.1. Glucose-induced insulin secretion and insulin content of islets. Supplemental Fig. 2.

The Mediterranean Diet: HOW and WHY It Works So Well for T2DM

New and Emerging Therapies for Type 2 DM

The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans

Endocrine Notes Mrs. Laux AP Biology I. Endocrine System consists of endocrine glands (ductless), cells, tissues secrete hormones

Supplementary Figures. T Cell Factor-1 initiates T helper 2 fate by inducing GATA-3 and repressing Interferon-γ

Supplementary Information

Hormones. Prof. Dr. Volker Haucke Institut für Chemie-Biochemie Takustrasse 6

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

Niki Prakoura. Calreticulin upregulation in renal fibrosis

SUPPLEMENTARY DATA. Supplementary Table 2. Antibodies used for Immunofluoresence. Supplementary Table 3. Real-time PCR primer sequences.

Treating Type 2 Diabetes with Bariatric Surgery. Goal of Treating T2DM. Remission of T2DM with Bariatric

ELSEVIER: UNCORRECTED PROOF

FH- FH+ DM. 52 Volunteers. Oral & IV Glucose Tolerance Test Hyperinsulinemic Euglycemic Clamp in Non-DM Subjects ACADSB MYSM1. Mouse Skeletal Muscle

18. PANCREATIC FUNCTION AND METABOLISM. Pancreatic secretions ISLETS OF LANGERHANS. Insulin

CB2-mediated immunoregulation in Inflammatory Bowel Disease. David Ziring, MD Clinical Instructor, UCLA Div of Peds GI

Neuroprotective properties of GLP-1 - a brief overview. Michael Gejl Jensen, MD Dept. Of Pharmacology, AU

Supplementary Information. Induction of human pancreatic beta cell replication by inhibitors of dual specificity tyrosine regulated kinase

Supplementary Information

Effect of macronutrients and mixed meals on incretin hormone secretion and islet cell function

Egr-1 regulates RTA transcription through a cooperative involvement of transcriptional regulators

Predictive PP1Ca binding region in BIG3 : 1,228 1,232aa (-KAVSF-) HEK293T cells *** *** *** KPL-3C cells - E E2 treatment time (h)

Deregulation of CREB Signaling Pathway Induced by Chronic Hyperglycemia Downregulates NeuroD Transcription

Bariatric Surgery MM /11/2001. HMO; PPO; QUEST 05/01/2012 Section: Surgery Place(s) of Service: Outpatient; Inpatient

Roux-and-Y Gastric Bypass and its Metabolic Effects

Cellular Signaling Pathways. Signaling Overview

Data Sheet. NFAT Reporter (Luc) Jurkat Cell line Catalog #: 60621

Hormonal regulation of. Physiology Department Medical School, University of Sumatera Utara

Cells and Tissues 3PART C. PowerPoint Lecture Slide Presentation by Patty Bostwick-Taylor, Florence-Darlington Technical College

Supplementary Table 1. The primers used for quantitative RT-PCR. Gene name Forward (5 > 3 ) Reverse (5 > 3 )

/05/$15.00/0 Molecular Endocrinology 19(10): Copyright 2005 by The Endocrine Society doi: /me

Cell Signaling part 2

My Journey in Endocrinology. Samuel Cataland M.D

Improving Diabetes Research: Moving Beyond Animal Models. Charu Chandrasekera, Ph.D. Anne Bunner, Ph.D.

Lecture 15. Signal Transduction Pathways - Introduction

Management of Type 2 Diabetes

PANCREATIC BETA CELLS PRODUCE AND SECRETE

NUTRIENT DIGESTION & ABSORPTION

Supplementary Figure 1 IL-27 IL

Receptor mediated Signal Transduction

Novel Physiological Role of Caveolin-1 in Aging and Aging-related Diseases. Sang Chul Park Gachon University Lee Gil Ya Cancer and Diabetes Institute

Supplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of

Hormonal Regulations Of Glucose Metabolism & DM

GLP 1 agonists Winning the Losing Battle. Dr Bernard SAMIA. KCS Congress: Impact through collaboration

Oat beta glucan: Multiple roles in the gut. A.R. Mackie, B.H. Bajka, B. Kirkhus

The Effects of Exenatide on the Autoimmune Development of Diabetes. A Senior Honors Thesis

GLP-1. GLP-1 is produced by the L-cells of the gut after food intake in two biologically active forms It is rapidly degraded by DPP-4.

Generating Mouse Models of Pancreatic Cancer

Control of Glucose Metabolism

History of Investigation

a b c Physical appearance of mice Lean mass Adipocyte size d e f

Gene expression in insulin resistance

SUPPLEMENTARY INFORMATION

Supplementary Figure 1

Insulin Resistance. Biol 405 Molecular Medicine

Hormones. BIT 230 Walsh Chapter 8

Preceptorship at the Yonsei Cancer Center Gastric Cancer Team. Date : July, 2018 Place: Yonsei Cancer Center, Seoul, Korea

Final Review Sessions. 3/16 (FRI) 126 Wellman (4-6 6 pm) 3/19 (MON) 1309 Surge 3 (4-6 6 pm) Office Hours

Incretins: Their physiology and application in the treatment of diabetes mellitus

Injectable GLP 1 therapy: weight loss effects seen in obesity with and without diabetes

Supplemental Data. Short Article. ATF4-Mediated Induction of 4E-BP1. Contributes to Pancreatic β Cell Survival. under Endoplasmic Reticulum Stress

Supplementary Information. Induction of p53-independent apoptosis by ectopic expression of HOXA5

Gene therapy: State of the art. Ramon Gomis MD, PhD, MAE. Hospital Clínic. IDIBAPS. University of Barcelona.

INTRODUCTION. Induction of Monocyte Chemoattractant Protein-1 (MCP-1) Expression by Angiotensin II (AngII) in the Pancreatic Islets and Beta Cells

Supplementary Figure 1: Steviol and stevioside potentiate TRPM5 in a cell-free environment. (a) TRPM5 currents are activated in inside-out patches

2013 W. H. Freeman and Company. 12 Signal Transduction

Pramlintide & Weight. Diane M Karl MD. The Endocrine Clinic & Oregon Health & Science University Portland, Oregon

Growth Hormone, Somatostatin, and Prolactin 1 & 2 Mohammed Y. Kalimi, Ph.D.

Regulation of cell function by intracellular signaling

New Drug Development for Hepatic Insulin Resistance

Neurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction. Laura Gunter

For more information about how to cite these materials visit

Supplementary Material

Sweetness and Glycaemic Regulation. (A focus on gut related and physiological aspects) John McLaughlin Manchester University

SUPPLEMENTARY INFORMATION

glucagon receptor AgRP merged color map I corr = 0.76±0.024 glucagon receptor DAPI merged

HORMONES AND CELL SIGNALLING

Making Mature Human Islet Cells from Stem Cells to Model Disease and Treat Diabetes

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

Transcription:

Exendin-4-mediated cell proliferation in beta-cells: focusing on the transcription factors Seo-Yoon Chang, Jae Min Cho, Yang-Hyeok Jo, Myung-Jun Kim Departments of Physiology, College of Medicine, The Catholic University of Korea

INS-1 cell - rat insulinoma cell line - glucose-responsive insulin secretion cf) RINm5F cell: glucose non-responsive due to the lack of GLUT2 Glucagon-like peptide-1 (GLP-1) - from enteroendocrine L-cell of ileum and colon in response to nutrient intake - in addition to glucose-dependent insulinotrophic action, inhibit glucagon secretion, gastric emptying, food intake - insulin biosysnthesis, insulin gene expression - proliferation, survival and growth of beta-cell

Proglucagon processing DNA mrna Protein Posttranslational processing cf) GLP-2: growth factor for gut Adapted from Gastroenterology 2007;132:2132-2157

GLP-1 s action in peripheral target tissues Adapted from Cell Metab 2006;3:153-165

GLP-1 receptor - coupled to G-protein - widely expressed in pancreatic islets, brain, heart, kidney, and the GI tract - only a single receptor isolated to date Signaling mechanism of GLP-1 receptor activation in beta-cells Adapted from Current Opin Pharmacol 2006; 6: 598-605

Signaling mechanism of GLP-1 receptor activation in beta-cells Adapted from Pharmacol Ther 2007;113:546-593

Short half-life of GLP-1 (several minutes) Adapted from Gastroenterology 2007;132:2132-2157

Exendins - from the venom of lizard Heloderma species; exendin-3 and exendin-4 - these peptides were named exendin since they were isolated from exocrine gland and were shown to have endocrine actions Exendin-4 - a potent agonist of glucagon-like peptide-1 (GLP-1) receptor - similar properties to native GLP-1 - in experimental diabetes model, improve glucose level, insulin secretion, weight loss, and food intake - stimulates islet mass increase and beta-cell proliferation - BYETTA (Amylin and Lilly)

Effects of glucagon-like peptide-1 on INS-1 cell proliferation. Adapted from Diabetologia 2004;47:478-487 Adapted from Diabetes 2003;52:124-132

Despite many reports about the GLP-1 s role in beta-cell proliferation, there was no report about the effect of GLP-1 on cyclin proteins. Cyclin D1 - a major regulator of G1 to S phases progression

EX induces cyclin D1 expression in INS-1 cells. Protein RNA Published J Endocrinol 2006;188: 623-633

GLP-1 receptor expression (A) and specificity (B). GLP1R antagonist: exendin-(9-39) amide GIPR antagonist: GIP-(6-30) from Dr. C M Isale (Georgia University, USA)

Effect of ERK1/2 on cyclin D1 expression. Though exendin-4 activates Raf-ERK pathway, there was no direct evidence in the involvement of ERK in exendin-4-induced cyclin D1 induction.

Mechanism of hormone action via camp as second messenger

Effects of forskolin and H-89 on cyclin D1 protein expression. FK: forskolin, camp increasing agent H89: a PKA antagonist Exendin-4-induced cyclin D1 expression seems to be dependent on intracellular camp concentration.

Involvement of CRE site in EX-induced cyclin D1 transcription. pcd1-96mt: mutated CRE site

CREB interacts with the putative CRE site of cyclin D1 promoter. mcre: mutated type wcre: wild type pcd1-96/vector: cotransfection of pcd1 and empty vector pcd1-96/creb: cotransfection of pcd1 and CREB expression vector pcd1-96/kcreb: cotransfection of pcd1 and dominant negative vector

Enhanced binding activity of phospho-creb to the putative CRE site of the rat cyclin D1 promoter in vivo.

Exendin-4 induces cyclin D1 expression via camp-pka signaling-mediated activation of CRE site within cyclin D1 promoter, and the interaction of phospho-creb with CRE site is implicated in both basal and exendin-4-induced cyclin D1 transcription.

Scheme of rat cyclin D1 promoter deletion constructs (A) and promoter analysis of cyclin D1 deletion construct (B). Published Diabetologia 2006;49:969-979

Characterization of other transcription factors in rat cyclin D1 expression. - Candidate: EGR1 E2F Sp1 Oct1 EGR/Sp1 CRE -827-700 -600-500 -400-300 -200-100 +43 Luciferase gene EGR1(5 ) EGR1(3 ) -176-73 EGR1 (early growth response-1) - one of immediate early gene, zinc-finger transcription factor - a upstream regulator of growth, proliferation and differentiation - involved in glucose-induced beta-cell growth

The relevance of EGR1 in beta-cell proliferation Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation. J Mol Endocrinol 2005;35:13-25. Activation of serum response factor in the depolarization induction of Egr-1 transcription in pancreatic Islet beta-cells. J Biol Chem 2000;275:25681-25689 Glucose induces early growth response gene (EGR1) expression in pancreatic beta cells. Diabetologia 1999;42:195-203. Egr-1 gene transcription and translation is rapidly induced by glucose treatment. Adapted from J Mol Endocrinol 2005;35:13-25

Proposed model for the regulation of PDX-1 expression by Egr-1 Adapted from J Biol Chem 2007;282:5973-83

Interaction of nuclear proteins with putative EGR1 binding sites. Exendin-4 Exendin-4

Characterization of the binding activity of 5 putative EGR1 site: Supershift assay (A) and Competition assay (B). wt: wild type EGR1 mut: mutated EGR1

Effect of mutation of the 5 putative EGR1 site on the cyclin D1 induction *, P < 0.05 vs. empty vector (pgl3 basic vector) #, P < 0.05 vs. pcd1-827

Recruitment of EGR1 to cyclind1 promoter in vivo.

Effect of EGR1 on cyclind1 promoter activity. Relative lu uciferase activity 5 4 3 2 1 pcr3.1 PCR3.1-EGR1 * 0 pcr3.1 pcd1-827 pcr3.1-egr-1

Exendin-4 rapidly induces transcription factor EGR-1 and this was bound the 5 EGR-1 binding site of rat cyclin D1 promoter. Through the EGR-1-mediated induction of cyclin D1 transcription, exendin-4 may contribute to beta-cell proliferation.

EX-induced EGR1 expression. A EX-4 0 15 30 60 180 (min) B EGR1 EGR1 (721 bp) GAPDH (452 bp) 82 kda EX-4 0 15 30 60 180 (min) Protein mrna C Fold Induction of EGR1 2.0 1.5 1.0 protein mrna 0.5 EX-4 0 15 30 60 180 (min) Published AJP-Endo & Metab 2007;292:E215-E222

Deletion analysis of rat EGR1 promoter. Fold induction p-462 2.1 p-324 SRE ETS CRE p-243 p-159 p-124 p-73 p-46 1.8 1.7 1.8 1.7 1.6 1.1 0 1 2 3 relative luciferase activity (fold induction)

Functional significance of proximal and distal CRE in EX-induced EGR1 expression. wild-462 distal CRE proximal CRE Fold induction 2.1 mpcre-462 mdcre-462 1.5 1.8 wild-73 1.7 mpcre-73 # 1.0 0 1 2 3 relative luciferase activity (fold induction)

Activation of proximal CRE site through binding of phospho-creb on Ser 133 by EX. consensus SP1 A B no competitor consensus CRE wild CRE mutant CRE consensus AP1 EX-4 0 5 15 30 60 (min)

Activation of proximal CRE site through binding of phospho-creb on Ser 133 by EX. no antibody anti-creb anti-pcreb anti-ap1 anti-sp1 no antibody anti-creb anti-pcreb anti-ap1 anti-sp1 C untreated exendin-4

Requirement of CREB phosphorylation on Ser 133 for EX induction of EGR-1 promoter. Vector: cotransfection of EGR-1 promoter and empty vector CREB: cotransfection of EGR-1 promoter and CREB expression vector Ser 133 Ala: cotransfection of EGR-1 promoter and mutant vector KCREB: cotransfection of EGR-1 promoter and dominant negative vector *, P < 0.05 vs. Vector, P < 0.05 vs. CREB

For the induction of EGR-1 transcription by exendin-4, the proximal CRE site of EGR-1 promoter is critical and the binding with CREB phosphorylated on Ser 133 is necessary.

EX-induced EGR expression via GLP-1 receptor. Fold Induction 2.0 1.5 1.0 Fold Induction 2.0 1.5 1.0 0.5 Egr-1 β-tubulin 0 0.1 1 10 100 EX-4 (nm) 82 kda 0.5 Egr-1 β-tubulin CON EX-4 EX-4+ EX-4+ GLPA GIPA 82 kda, P<0.05 vs. untreated control value, P<0.05 vs. 1 nm, P<0.05 vs. untreated control value Published J Cell Biochem 2008;104:2261-2271

H-89 and PD 98059 inhibit EX-induced Egr-1 protein expression. A Fold Induction 2.5 2.0 1.5 1.0 0.5 CON EX-4 FK PD H89 H89+ H89+ PD+ EX-4 FK EX-4 B Egr-1 28S 18S H89+ H89+ PD+ CON EX-4 FK PD H89 EX-4 FK EX-4 Egr-1 β-tubulin 82 kda, P<0.05 vs. CON, P<0.05 vs. EX-4

The involvement of camp and ERK in EX-induced Egr-1 expression. C1 PKA (nm) C2 ERK1 (nm) Scr 10 50 100 Scr 10 50 100 PKA Erk1 44 kda 42 kda EX-4 Scr PKA - + - + EX-4 Scr ERK1 - + - + Egr-1 82 kda Egr-1 82 kda β-tubulin β-tubulin 2.0 2.0 Fold Induction 1.5 1.0 Fold induction 1.5 1.0 0.5 *, P < 0.05 vs. untreated;, P < 0.05 vs. EX-4 in Scr. 0.5 *, P < 0.05 vs. untreated;, P < 0.05 vs. EX-4 in Scr.

ccgcggag cctcagctct acgcgcctgg cgccctccct acgcgggcgt -463 ccccgactcc cgcgcgcgtt caggctccgg gttgggaacc aaggaggggg SRE1 agggtgggtg cgccgacccg gaaacaccat ataaggagca ggaaggatcc SRE2 SRE3 cccgccggaa cagaccttat ttgggcagcg ccttatatgg agtggcccaa tatggccctg ccgcttccgg ctctgggagg aggggcgaac gggggttggg gcgggggcaa gctgggaact ccaggagcct agcccgggag gccactgccg ctgttccaat actaggcttt ccaggagcct gagcgctcag ggtgccggag CRE ccggtcgcag ggtggaagcg cccaccgctc ttggatggga ggtcttcacg SRE4 YY-1 tcactccggg tcctcccggt cggtccttcc atattagggc ttcctgcttc SRE5 CRE ccatatatgg ccatgtacgt cacggcggag gcgggcccgt gctgtttcag +1 acccttgaaa tagaggccga ttcggggagt cgcgagagat cccagcgcgc +26 agaacttgg

Transcription factor: regulate transcription (activator or repressor) Zinc finger protein Adapted from Nucleic Acids Res 1994;22:5151-5155

Identification of SRE clusters implicated in transcriptional regulation of rat Egr-1 gene by EX. A pegr-462 dsres CRE psres CRE +1 Fold induction 2.09 pegr-324 * 1.76 pegr-462 p -124-75 * 1.72, P<0.05 vs. control of pegr-462, P<0.05 vs. control of pegr-324 and pegr-p462 p pegr-324 p * CON EX-4 1.58, P<0.05 vs. EX-4-treated pegr-462, P<0.05 vs. EX-4-treated pegr-324 p and pegr-462 p B 0.0 0.5 1.0 1.5 2.0 relative luciferase activity relative luciferase activity (fold induction) 1.0 0.5 psg5 psg5-yy1 0.0 pegr-124 pegr-46

Gel mobility shift assay of SRE site on rat Egr-1 promoter. From -113, 5 -cggtccttccatattagggcttcctgc-3 A1 EX-4 (min) A2 EX-4 (min) A3 Com 0 10 30 60 Com 0 10 30 60 2.5 SRF SP1 Rela ative density (S SRF/SP1) 2.0 1.5 1.0 0.5 0.0 0 10 30 60 EX-4 (min)

Gel mobility shift assay of SRE site on rat Egr-1 promoter. B C Competitor WT MT CONS YY1 Ab SRF p-srf Elk YY1 Sp1

EX-4-induced Egr-1 expression appears to be largely dependent on camp/pka signaling pathway in β-cells. The interaction of both SRF and phospho-srf with SRE site of the Egr-1 promoter may be implicated in both basal and EX-4-induced Egr-1 transcription.

Exendin-4 increased cyclin D1 expression via activation of CRE site and EGR1 binding site within cyclin D1 promoter in INS-1 beta-cells. Exendin-4 increased EGR1 expression via interaction of 1) CREB to proximal CRE site and 2) SRF to SRE site of EGR1 promoter. Exendin-4 serves as a growth factor regulating beta-cell proliferation.

Lab Member Prof. Yang-Hyeok Jo Postdoc. Jung-Hoon Kang (NIH) Assistant Seo-Yoon Chang Student Jae Min Cho In collaboration with Assist. Prof. In-Kyung Jeong (Dept. of Internal Medicine, Kyung Hee Univ.) Assist. Prof. Seung Hyun Ko (Dept. of Internal Medicine, Catholic Univ.) Gyeong Ryul Ryu, Ph. D. (Dept. of Internal Medicine, Catholic Univ.) Human cyclin D1 pomoter: Dr. O. Tetsu and Dr. F. McCormick (Univ. of Calif.-San Francisco) pcmv-erk1: Dr. P. E. Shaw (Univ. of Nottingham, UK) Mutant CREB(Ser 133 Ala) and KCREB: Dr. R.H.Goodman (Oregon Health and Science Univ.) Financial support Korea Science and Engineering Foundation (R-2004-000-10127-0) Korean Diabetes Association (BAYER, 2005)